Duality Biologics Announces B7H4 ADC Milestone Achievement and License Exercise by BeiGene
SOMERSET, N.J., SHANGHAI and SUZHOU, China, Dec. 31, 2024 /PRNewswire/ -- Duality Biologics ("DualityBio") announced that, BeiGene. Ltd. has exercised its exclusive option for the B7H4 antibody-drug conjugate (ADC) DB1312/BG-C9074 from DualityBio,...
Ambow Education Announces Second Quarter and First Half of 2024 Financial Results
CUPERTINO, Calif., Dec. 31, 2024 /PRNewswire/ -- Ambow Education Holding Ltd. ("Ambow" or the "Company") (NYSE American: AMBO), a leading AI-driven educational and collaboration technology company, today announced its unaudited financial and...
NOBLE Registry Update: TLX599-CDx PSMA SPECT Imaging of Prostate Cancer Published in EJNMMI Reports
MELBOURNE, Australia and BRUSSELS, Dec. 31, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) and the Brussels-based Oncidium foundation today announce that results for the NOBLE Registry of TLX599-CDx...
I Peace manufactures 100 lines of GMP iPS Cells cumulatively
Proof of customer recognition of its quality and mass manufacturing capability PALO ALTO, Calif., Dec. 31, 2024 /PRNewswire/ -- Leading GMP cell CDMO I Peace, Inc. (https://ipeace.com/en/), specializing in induced pluripotent stem cells (iPSCs) and...
Watch the Official Delta Force "Serpentine" PvE Raid Trailer
LOS ANGELES, Dec. 31, 2024 /PRNewswire/ -- Prepare for an all-new type of Delta Force challenge. Operation Serpentine drops you and your squad behind enemy lines and into a dangerous PvE Raid, available starting January 1, 2025. Choose your gear,...
Dataloy Caps Off 2024 with Record Growth and Q4 Innovations Driving Maritime Excellence
Closing 2024 with close to 25% revenue growth, including a strong fourth quarter, Dataloy Systems continues to strengthen its position in maritime digitalisation. BERGEN, Norway, Dec. 30, 2024 /PRNewswire/ -- Dataloy Systems, a global leader in...
CapitaLand Investment advances Sustainability leadership in 2024 by progressing toward decarbonisation milestones and recognition in leading global indexes
13th consecutive year on the Dow Jones Sustainability World Index and 16th straight year on the Asia Pacific Index, following MSCI, FTSE4Good and GRESB accolades Increased focus on identifying and reducing material Scope 3 emissions and heightened...
Bridge Biotherapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
SEONGNAM, South Korea and BOSTON, Dec. 30, 2024 /PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a clinical-stage biotech company based in South Korea developing novel drugs for fibrosis and cancer, today announced that James Jungkue Lee, Founder...